Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,542 | 743 | 56.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,915 | 5 | 40.1% |
| Travel and Lodging | $744.52 | 2 | 3.4% |
| Education | $9.46 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $11,919 | 300 | $0 (2024) |
| Allergan, Inc. | $1,250 | 1 | $0 (2021) |
| Medtronic, Inc. | $1,066 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $811.78 | 63 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $688.60 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $645.05 | 26 | $0 (2024) |
| Gilead Sciences, Inc. | $597.64 | 17 | $0 (2024) |
| Novo Nordisk Inc | $520.77 | 40 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $506.80 | 37 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $416.60 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,499 | 208 | Medtronic, Inc. ($1,027) |
| 2023 | $2,700 | 173 | ABBVIE INC. ($957.54) |
| 2022 | $4,279 | 171 | ABBVIE INC. ($2,560) |
| 2021 | $10,732 | 199 | AbbVie Inc. ($7,389) |
All Payment Transactions
751 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: VIROLOGY | ||||||
| 12/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Durable Pump | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Neuropsychiatry | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Rare Disease | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.01 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.27 | General |
| Category: PAIN | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: VIROLOGY | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 173 | 549 | $101,496 | $20,227 |
| 2022 | 3 | 217 | 615 | $85,345 | $26,600 |
| 2021 | 5 | 260 | 742 | $77,795 | $29,312 |
| 2020 | 6 | 298 | 906 | $99,195 | $36,339 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 84 | 294 | $48,241 | $9,937 | 20.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 47 | 178 | $36,552 | $6,144 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 77 | $16,704 | $4,146 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 344 | $37,989 | $14,430 | 38.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 44 | 119 | $13,040 | $4,222 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 56 | $8,680 | $3,746 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 41 | 78 | $20,177 | $3,140 | 15.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 18 | $5,459 | $1,063 | 19.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 98 | 306 | $33,660 | $15,318 | 45.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 67 | 261 | $28,710 | $8,334 | 29.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 45 | $6,975 | $3,147 | 45.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 45 | 87 | $5,655 | $1,319 | 23.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 43 | $2,795 | $1,194 | 42.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 110 | 424 | $39,760 | $15,631 | 39.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 218 | $28,075 | $11,051 | 39.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 65 | 201 | $22,830 | $6,638 | 29.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 18 | 29 | $4,720 | $1,427 | 30.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $2,640 | $1,322 | 50.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 14 | 18 | $1,170 | $268.96 | 23.0% |
About Michelle Davis, NP
Michelle Davis, NP is a Nurse Practitioner healthcare provider based in Athens, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2012. The National Provider Identifier (NPI) number assigned to this provider is 1881951994.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Davis, NP has received a total of $22,211 in payments from pharmaceutical and medical device companies, with $4,499 received in 2024. These payments were reported across 751 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($12,542).
As a Medicare-enrolled provider, Davis has provided services to 948 Medicare beneficiaries, totaling 2,812 services with total Medicare billing of $112,478. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Athens, TN
- Active Since 04/13/2012
- Last Updated 11/12/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1881951994
Products in Payments
- UBRELVY (Drug) $9,511
- MINIMED 780G (Device) $1,027
- VRAYLAR (Drug) $873.62
- TRELEGY ELLIPTA (Drug) $791.33
- MAVYRET (Drug) $748.38
- LifeVest (Device) $688.60
- RINVOQ (Biological) $626.87
- CAPLYTA (Drug) $502.77
- NURTEC ODT (Drug) $446.30
- XIFAXAN (Drug) $442.39
- SKYRIZI (Biological) $320.14
- ELIQUIS (Drug) $309.29
- LINZESS (Drug) $237.41
- ZENPEP (Drug) $232.96
- HUMIRA (Biological) $214.38
- FASENRA (Biological) $207.55
- CREON (Drug) $203.78
- Wegovy (Drug) $200.86
- Epclusa (Drug) $193.44
- Ozempic (Drug) $189.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Athens
Sue Phelps
Nurse Practitioner — Payments: $11,259
Andrea Mealor, Np, NP
Nurse Practitioner — Payments: $7,599
Ms. Holly Collier, Np, NP
Nurse Practitioner — Payments: $6,030
Tina Hale, N.p, N.P
Nurse Practitioner — Payments: $5,709
Neha Patel, Crnp, CRNP
Nurse Practitioner — Payments: $5,145
Andrew Gonzales, Fnp-C, FNP-C
Nurse Practitioner — Payments: $4,514